Long-term Toxicity and Survival Outcomes After Stereotactic Ablative Radiotherapy for Patients with Centrally Located Thoracic Tumors

BACKGROUND: Stereotactic ablative radiotherapy (SABR) is effective for thoracic cancer and metastases; however, adverse effects are greater for central tumors. We evaluated factors affecting outcomes and toxicities after SABR for patients with primary lung and oligometastatic tumors. PATIENTS AND ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Atalar, Banu, Mustafayev, Teuta Zoto, Sio, Terence T., Sahin, Bilgehan, Gungor, Gorkem, Aydın, Gokhan, Yapici, Bulent, Ozyar, Enis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585334/
https://www.ncbi.nlm.nih.gov/pubmed/32589607
http://dx.doi.org/10.2478/raon-2020-0039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585334/
https://www.ncbi.nlm.nih.gov/pubmed/32589607
http://dx.doi.org/10.2478/raon-2020-0039

Ejemplares similares